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The Schiff base ligand obtained from the reaction of 2-amino-3-hydroxypyridine, 2,4,6-trihydroxy benzaldehyde is 
described. Cu(II), Ni(II), Co(II), and Zn(II)complexes have been analyzed by various spectroscopic techniques like FT-IR, 
UV-visible, mass spectrometry and NMR. Based on spectral data octahedral geometry has been assigned to the complexes. 
In the present study the prepared Schiff base ligand and all the metal complexes have been synthesized and studied for their 
in vitro anti diabetic, antioxidant and antibacterial activities. Geometry optimization and the chemical stability and reactivity 
of complexes clearly understood with help of frontier molecular orbital’s (HOMO-LUMO) using B3LYP/LACVP++ basis 
sets based on density functional theory. Furthermore, Molecular docking study of the Schiff base ligand and their metal (II) 
complexes showed good binding score with human pancreatic α-amylase (PDB: 1HNY). 
Keywords: Antibacterial, Antidiabetic, Antioxidant, Computational, Docking 
Schiff bases are an important class of ligands in 
coordination chemistry and find extensive applications 
in different fields. Thus the main aim of this study was 
to design new Schiff base containing 2,4,6-trihydroxy 
benzaldehyde, 2-amino-3-hydroxypyridine the Cu(II), 
Ni(II), Co(II) and Zn(II) complexes were prepared and 
characterized. Recent years a great deal of interest in the 
synthesis and characterization of Schiff bases involving 
a pyridine ring. Pyridine ligands, which have been used 
in the coordination chemistry of a variety of metals 
1-4
 
occupy a unique position in the synthesis of biologically 
active compounds.
5-6
 In this study, we have described 
synthesis, characterization, with some new tridentate 
Schiff base ligands, which have been characterized by 





NMR and mass spectrometry. We have also investigated 
antibacterial activity of the complexes against 
Pseudomonas aeruginosa, Escherichia coli, Staphylococcus 
aureus, Bacillus subtilis.  
The objective of the present study was to 
investigate the antioxidant activity of Schiff base 
ligand and their metal complexes, compared with that 
of the classical antioxidants, Vitamin C by in vitro 
total antioxidant activities (phosphomolybdenum 
methods) radical scavenging method. Therefore, in 
addition to natural antioxidants such as Vitamin E, 
Vitamin C, flavonoids and carotenoids with free 
radical scavenging potential may be relevant in the 
therapeutic and preventions of diseases
7
. The 
development of anti-diabetic metal complexes 
replacing insulin injection to regulate sugar levels 
appears to be interesting. Inhibition of α-amylase is an 
important enzyme which is secreted primarily by the 
salivary glands and the pancreas and to control post-
prandial hyperglycemia. Diabetes mellitus (DM) is a 
metabolic disorder was resulting from a defect in 
insulin secretion, insulin action, or both leading 
to chronic hyperglycemia it is often accompanied 
with disturbances of carbohydrate, fat and protein 
metabolism and severe diabetic complications. The 
increased oxidative stress in different tissues of 
diabetic patients is caused by chronic hyperglycemia 
and plays a central role in the development of 
various associated complications including retinopathy, 
neuropathy, nephropathy, cardiovascular complications 
and ulceration
8–13
. Here we studied about anti diabetic 
activity in alpha-amylase method with various 
concentrations, the molecular docking study, geometry 
optimization and DFT calculations are also done for 
the prepared Schiff base ligand and its metal(II) 
complexes. 
Materials and Methods 
The chemical compound 2-amino-3-hydroxy 
pyridine obtained from Avra synthesis, 2,4,6-
trihydroxy benzaldehyde obtain from sigma Aldrich, 
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metal(II) chloride salts are obtained from Sisco 
Research Laboratories (SRL) and used without any 
further purification. The solvents used for synthesis, 
purification process and other spectroscopic techniques 
were prior to using standard distillation process.
14
 
Infrared spectra were examined on a Perkin-Elmer 
FT-IR type 1650 spectrophotometer and UV-visible 
spectra in Perkin-Elmer Lambda-25 in the wavelength 
range 200–600 nm. The ESI-mass spectral techniques 
were performed in ESI-mass spectrophotometer using 
methanol as a solvent. The 
1
H NMR and 
13
C NMR 
spectra of the ligand were recorded with a Bruker 400 
MHz NMR spectrophotometer. Theoretical and 
molecular docking studies carried using Schrodinger 
suite-2015 program. 
 
Preparation of Schiff base ligand (HL) 
To a methanolic solution of 2,4,6-trihydroxy 
benzaldehyde (2 mmol) refluxed with stirring by 
equimolar quantities of 2-amino-3-hydroxy pyridine  
(2 mmol) at 80 °C for 4 h. The resulting yellow solution 
was filtered and recrystallized with methanol. The 
obtained product was followed by TLC, after that the 
ligand was dried in vacuum desiccators. The obtained 
ligand is stable in air. Yield: 71%; Color: Dark brown; 
M.P. >250 °C; 
1
H NMR (DMSO-d6, δ, PPM): 5.75 
(s,1H,C-OH), 6.39–8.25 (m,1H,Ar-H), 9.23 (s,1H, 
N=CH);
13
C NMR (DMSO-d6,δ, PPM): 112.86–
139.91(Ar-C), 150.71(C=N);. IR (ν, cm
−1
): 1557 
(ν CH=N); 3324 (ν C=OH); λmax(nm) in MeOH: 429, 
312, 224; Positive-ion ESI–MS (MeOH) m/z (%): 245. 
 
Synthesis of the complexes [M (HL)] (1a-1d) 
To a methanolic solution Schiff base ligand (HL) 
(1mmol) mixing with methanolic solution of metal(II) 
chloride salts like Cu, Ni, Co and Zn (2 mmol) with 
constant stirring and reflux at 80 °C for 8 h. The 
resulting mixture was allowed to cool at room 
temperature and the resultant product was filtered, 
washed with cold methanol and dried. The obtained 
product was recrystallized from hot methanol and 
dried over in vacuum desiccator. 
 
Synthesis of [Cu(HL)] (1a) 
Yield: 67; Color: Brown; M.P. >300 °C (dec.); IR (ν, 
cm
−1
) : 1548(ν C=N); 3610 (ν C=OH); 464( ν Cu-N), 
587(ν Cu-O); λmax (nm)) in MeOH: 462 (d-d), 393, 336, 
259; Positive-ion ESI–MS (MeOH) m/z (%): 551. 
 
Synthesis of [Ni(HL)] (1b) 
Yield: 66%; Color: Light Brown; M.P.>300 °C 
(dec.); IR (ν, cm
−1
) :1571(ν C=N); 3547 (ν C=OH); 
464( ν Cu-N), 587(ν Cu-O); λmax (nm) in MeOH: 433 
(d-d), 309, 271, 220; Positive-ion ESI–MS (MeOH) 
m/z (%): 545. 
 
Synthesis of [Co(HL)] (1c) 
Yield: 63%; Color: Dark Brown; M.P. >300 °C 
(dec.); IR (ν, cm
−1
) : 1567(ν C=N); 3648 (ν C=OH); 
467( ν Cu-N), 586(ν Cu-O); λmax (nm)) in MeOH: 429 
(d-d), 312, 244, 224; Positive-ion ESI–MS (MeOH) 
m/z (%): 546. 
 
Synthesis of [Zn(HL)] (1d) 
Yield: 64%; Color: Coffee brown; M.P. >300 °C 
(dec.); IR (ν, cm
−1
) : 1571(ν C=N); 3547 (ν C=OH); 
463( ν Cu-N), 567(ν Cu-O); λmax (nm)) in MeOH: 423 
(d-d), 313, 213, 226; Positive-ion ESI–MS (MeOH) 
m/z (%): 551. 
 
Antibacterial activity 
In-vitro antibacterial activity against Escherichia 
coli, Staphylococcus aureus, Pseudomonas aeruginosa, 
Bacillus subtilis were screened and assayed by disc 




The total antioxidant potential were evaluated by 
using the phosphomolybdenum method. The total 
antioxidant capacity was based on the reduction of 
Mo(VI) to Mo(V) by accepting an electron from an 
antioxidant at acidic pH. 
 
Antidiabetic activity 
The antidiabetic activity was performed by using α-
amylase inhibition method. Amylase (0.5 mg/mL) 
was incubated with and without extract and standard 
for 10 min at 25 °C. This experiment was performed 
in 20 mM sodium phosphate buffer (pH 6.9). After 
pre incubation, the 1% starch solution (1mL) was 
added and the reaction mixture was incubated for 30 
min at 25 °C. 
 
Molecular docking 
The rigid molecular docking studies were 
performed by using maestro-v10.2 software integrated 
into the Schrodinger 2015-2 molecular modelling 
package installed on Intel Pentium 32 bit; x64 
processor-based hp workstation with a Windows-10 
operating system. The 3D structures of the complexes 
were sketched by using builder panel in maestro and 
fully optimized using the Ligprep module which 
executes addition of the hydrogen, regulates the 
rational bond angles and lengths, and adjusts the 
geometry and ring conformations.  




The crystallographic data of human pancreatic  
α-amylase (PDB:1HNY) were retrieved from Protein 
Data Bank (http://www.rcsb.org). Consequently, the 
receptor was fully optimized in the protein 
preparation wizard. In this stage it involves aligning 
bond order, adding polar hydrogen, delete water 
beyond 5Å from hetero atoms, adding missing side 
chain and finally incorporation of hydrogen bond 
corresponding to PH 7.0. The outputs were visualized 




All the computational works were performed  
using jaguar v8.8 program as incorporated in 
Schrödinger suite 2015-2. The geometry optimization 
and the quantum chemical calculation of metal 
complexes and Schiff base ligand were optimized 
based on the density functional theory (DFT) using 
the B3LYP functional and 3-21G*++ basis set was used 
in all cases. 
 
Results and Discussion 
The Schiff base ligand (HL) was characterized by 
FT-IR, UV-visible and 
1
H NMR techniques. The metal 
(II) complexes (1a–1d) were prepared by treating 
metal chlorides with the Schiff base ligand using 
methanol as solvent. The complexes have been 
isolated as a pure and stable compound. Based on 
coordination towards metal ions, the complexes were 
formulated as [Cu(HL)]1a, [Ni(HL)]1b, [Co(HL)]1c 
and [Zn(HL)]1d. All the complexes were quite soluble 
in common organic solvents such as methanol, 
ethanol, DMF and DMSO, less soluble in water and 







C NMR spectra of the samples were 
recorded on Bruker 300 MHz and 75 MHz 
spectrometer. The chemical shifts are reported in ppm 
(δ) with TMS as internal standard. The 
1
H NMR study 
is to help in the structural elucidation of the ligands as 
well as in locating precisely the donor site or sites of a 
ligand. The 
1
H NMR spectra of the ligand shows the 
signals at 6.39–8.25 (m) δ for aromatic protons and 
9.23 (s)δ for azomethine proton. The peak at 5.75 (s)δ 
attributed to –OH group they shown in Supplementary 
Data, Fig. S1.
13
C NMR spectra of Schiff base ligand 
showed the azomethine carbon signal at 150.71 ppm. 
The aromatic carbon signals are seen at 112.86–
139.91 ppm range depending on their electronic 
environment in Supplementary Data, Fig. S2. 
ESI-mass spectra (TOF-MS) of the Schiff base 
ligands and their complexes were recorded on 
micromax Q-TOF model with ES+ mode in methanol. 
The mass spectrum of the Schiff base ligand (HL) 
showed the molecular ion peak at m/z 245 
corresponding to [C12H10N2O5] ion. Also the spectrum 
exhibited peaks for the fragments at m/z 123 and  





respectively. The spectra of Cu(II), Ni(II), Co(II) and 
Zn(II) complexes showed molecular ion peaks at m/z 
551, 545, 546 and 551, respectively that are 
equivalent to their molecular weight they shown in 
Supplementary Data, Figs S3 and S4. The fragment 
ion peak is observed at m/z 246 which corresponds to 
the original molecular weight of the Schiff base under 
investigation.  
Selected infrared vibrational stretching frequencies 
of the free Schiff base ligand and the metal 
complexes, which are useful for determining the 
mode of coordination of the ligand. The FT-IR spectra 
of Schiff base ligand and metal(II) complexes (1a-
1d). The spectrum of the ligand HL shows a broad 
band in the region 3324 cm
−1
 assignable to 
intramolecular hydrogen bonded OH groups. The 
absence of these bands, noted in the spectra of the 
complexes, indicates the deprotonation of the 
intramolecular hydrogen bonded OH groups on in the 
region of 3438–3648 cm
−1
. The spectra of the ligand 
show the characteristic –C=N bands in the region 
1557–1564 cm
−1
, which are shifted to lower frequencies 
in the spectra of the complexes (1548–1571 cm
−1
) 
indicating the involvement of the azomethine nitrogen 
in chelation with the metal ion. The IR spectra of  
the metal complexes also show some new bands in  
the region 450–467 cm
−1
 and 500–587 cm
−1
 which are 
 
 
Scheme 1 — Synthesis of Schiff base ligand and its metal(II) 
complexes 
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probably due to the formation of M-O and M-N 
bonds
15-16
, respectively (Supplementary Data, Fig. S5). 
The molecular electronic absorption spectra of the 
free Schiff base ligand and the metal complexes are 
often very important in the evaluation of results 
furnished by other methods of structural check. The 
electronic spectral measurements were used for 
assigning the stereo chemistries of metal ions in the 
complexes depending on the sites and number of d–d 
transition peaks. The electronic absorption spectra of 
ligands and their complexes were registered at the 
wavelength range 200–600 nm and at 298 K. The ligand 
exhibits absorption bands in UV–visible region around 
355 nm which is assigned to n→π* transition originating 
from the imine function of the Schiff base ligand. The 
absorption bands of complexes at λmax= 390–407 nm is 
assigned to charge transfer with in Schiff base ligands. 
Furthermore a long and broad band lying in the region 
423–462 nm could be mainly attributed to the d → d 
transition in the structure of the prepared complexes 
shown in Supplementary Data, Fig. S6. 
 
Antibacterial activity 
In vitro antibacterial activity of The Schiff base 
ligand (HL) and its metal (II) complexes (1a-1d) have 
been screened and assayed by disc diffusion method 
against various pathogenic bacterias such as Pseudomonas 
aeruginosa, Escherichia coli, Bacillus subtilis, 
Staphylococcus aureus, ciprofloxacin were used as the 
standard for bacterial studies. Furthermore, the zone of 
inhibition study revealed that the synthesized compounds 
possessed antibacterial activity against the tested 
microbes as described in Table 1 and Supplementary 
Data, Fig. S7. It has been observed that the metal 






Total antioxidant capacity (Phosphomolybdenum assay) 
The total antioxidant potential of the Schiff base 
ligand and their metal complexes were evaluated by 
using the phosphomolybdenum method
23
 which is 
based on the reduction of Mo(VI) to Mo(V) by 
accepting of an electron from antioxidant at acidic 
pH. Total antioxidant activities of ligand and complex 
were observed. About 3 mL of antioxidant reagent 
(0.6 M H2SO4, 28 mM Na3PO4 and 4 mM ammonium 
molybdate) were added to the test samples with 
various concentrations (10, 50, 100, 250 and 500 
μg/mL). The test mixture to accomplish proper 
diffusion with phosphomolybdenum reagent was 
incubated at 95 °C for 90 min in a water bath. The 
total antioxidant activity of extracts and vitamin C 
standard drug were measured and determined their 
absorbance at 695 nm using a spectrophotometer. The 
total antioxidant activities were calculated using the 
given formula. 
 
                        …(1) 
 
Where At is absorbance of test and Ac is 
absorbance of control. The results of total antioxidant 
capacity of Schiff base ligand (HL) and their metal 
Cu(II)1a, Ni(II)1b, Co(II)1c, and Zn(II)1d complexes 
were summarized as respectively in Table 2 and in 
Supplementary Data, Fig. S8. Among the tested 
compounds Cu(II)1a complex shows the maximum 




α-Amylase inhibition technique 
The α-Amylase inhibitory activity of this Schiff 
base ligand and metal complexes was performed by 
using α-Amylase inhibition method with various 
concentrations (10, 50, 100, 250 and 500 μg/mL) 
according to our former publication.
24 
Briefly, 
Amylase (0.5 mg/ml) was incubated with and without 
extract and standard for 10 min at 25 °C. This 
experiment was performed in 20 mM sodium 
phosphate buffer (pH 6.9). After pre incubation, the 
1% starch solution (1mL) was added and the reaction 
mixture was incubated for 30 min at 25 °C. In order to 
Table 1 — Antibacterial activity of Schiff base ligand (HL) and metal(II) complexes (1a-1d) of against Pathogenic bacteria by disc 
diffusion method 
Compounds Inhibition Zone (mm) 
P. aeruginosa E. coli S. aureus B. subtilis 
HL 9 11 14 13 
1a 11 13 11 14 
1b 9 11 16 20 
1c 12 14 11 15 
1d 13 12 13 17 
Ciprofloxacin 12 13 17 24 




stop the enzymatic reaction, DNSA reagent (1mL) 
was added as the colour reagent and then incubated in 
a boiling water bath for 15 min. After cooling down to 
the room temperature, the absorbance measured at 
540 nm using a spectrophotometer instrument. The 
measured absorbance was compared with that of the 
control experiment. The percentage inhibition was 
calculated from the given formula 
 
                                   …(2) 
 
Where, At is absorbance of test and Ac is 
absorbance of control. The measured absorbance was 
compared with that of the control experiment and the 
obtained results were considered as criteria for the 
percentage of α -Amylase inhibition.
25,26
 As shown, 
Schiff base ligand (HL) and metal complexes 
(Cu(II)1a, Ni(II)1b, Co(II)1c, and Zn(II)1d) revealed 
an inhibitory action similar to the widely used 
commercial drug (Acarbose) against pancreatic α –
Amylase. The compounds were summarized as 
respectively in Table 3 and in Supplementary Data, 
Fig. S9. Among the tested compounds Co(II)1c 
complex shows the maximum antidiabetic activity. 
 
Molecular docking studies 
The molecular docking calculation based on the 
most probable interaction between the drug 
molecules
27
 and a target protein. In this docking 
study, the molecular interaction of Schiff base ligand 
and its metal complexes was chosen to predict the 
binding site inside the target protein, To study the 
molecular interaction of compounds, crystallographic 
data of human pancreatic α-amylase (PDB:1HNY) 
was retrieved from Protein Data Bank. In the protein 
preparation wizard, first manually removing bound 
ligands and water (beyond 3Å) molecules followed by 
addition of hydrogen to the protein.  
Thereafter, minimization was carried out using force 
field OPLS-2005 until it reached a cut-off 0.01Å 
RMSD. The complex structures were constructed by 
using CHEM SKETCH and converted into PDB format 
suitable for docking program using OPENBABEL. The 
output results were visualized with help of PyMOL. The 
docking score value and various modes of binding 
interaction with the target protein predicted in Figs 1 & 2 
and the data were summarized in Table 4. The figure 
give a clear idea about that the active sites of docked 
protein well stabilized by H-bond, π-π stacking 
interactions, and hydrophobic contacts. The docking 
score values of ligand and metal(II) complexes were 
found to be −5.511, −4.436, −5.372, −3.577 and −5.193 
kcal mol
−1
. When the docking scores value is more 
negative, the binding nature of a complex with the 
receptor is greater. 
 
Computational analysis 
Theoretical investigation of Schiff base ligand (HL) 
and its metal(II) complexes were performed using jaguar 
v8.8 program as incorporated in Schrödinger suite 2015-
2. The geometries of metal(II) complexes (1a-1d) were 
optimized based on the density functional theory (DFT) 
using the B3LYP/LACVP++ basis set was used  
in all cases. 
Table 2 — Antioxidant activity of Schiff base ligand (HL) and metal(II) complexes (1a-1d) with various concentrations 
Compounds Concentration (μg/mL) 
10 50 100 250 500 
HL 10.12 15.44 33.45 48.71 56.92 
1a 11.11 16.38 34.58 47.25 58.82 
1b 10.78 16.02 34.26 47.11 58.56 
1c 11.09 16.13 34.47 47.21 58.69 
1d 10.24 15.51 33.67 46.77 57.35 
Vitamin C 22.43 32.11 69.78 82.23 94.55 
 
Table 3 — Antidiabetic activity of Schiff base ligand (HL) and metal(II) complexes (1a-1d) with various concentrations 
Compounds Concentration (μg/mL) 
10 50 100 250 500 
HL 6.72 10.33 29.82 39.47 51.57 
1a 5.89 11.72 31.33 41.22 54.59 
1b 5.68 11.42 31.27 41.51 54.18 
1c 5.95 11.96 31.94 41.76 54.90 
1d 5.77 11.36 31.28 40.64 54.02 
Acarbose 18.22 26.33 44.69 63.29 81.52 
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Frontier molecular orbital 
The frontier molecular orbitals Schiff base ligand 
(HL) and its metal(II) complexes (1a-1d) were 
represented in Fig. 3. The chemical stability or 
reactivity of compounds associated with a function of 
frontier molecular orbital’s (FMO's).
28
 It involves an 
interaction of energy levels between HOMO and 
LUMO of the reacting molecules. The highest 
 
 




Fig. 2 — 3D (a-d) and 2D (e-h) interaction of Cu(II) 1a, Ni(II) 1b, Co(II) 1c and Zn(II) 1d complexes 
 




occupied molecular orbital’s (HOMO) capable of 
donating electrons to the empty orbital’s of acceptor 
molecules while lowest unoccupied molecular orbitals 




The important quantum parameters like HOMO–
LUMO energy gap (ΔE), chemical potentials (Pi), 
absolute electronegativities (χ), absolute softness (σ), 
absolute hardness (η), global electrophilicity (ω), 
global softness (S), and additional electronic charge 





                …(3) 
 
   




    
             
 
 …(5) 





       ….(7) 
 





   




      
   
 
 …(10) 
The energy difference between (ΔE) ELUMO and 
EHOMO more abundantly determine the activity of 
compounds. The observed energy band gap values for 
Schiff base ligand (HL) and its metal complex, 
Cu(II)1a, Ni(II)1b, Co(II)1c and Zn(II)1d is found to 
be 4.77 eV, 1.07 eV, 2.46 eV, 3.41 eV and 1.17 eV, 
respectively. It was found that the Cu(II) 1a complex 
showed lowest band gap and easier to transits electron 
from ground (HOMO) state to excited state (LUMO) 
at low frequency compared to other complexes. The 
calculated quantum parameters are listed in Table 5. 
 
Geometry optimization 
The geometry optimization for synthesized Schiff 
base ligand (HL) and metal(II) complexes (1a-1d) 
were   carried  out   by   maestro  software   inbuilt  in  
 




Active sites with a mode of interaction 
H-bond π-π stacking Hydrophobic contacts 
HL -5.511 ARG 10, ASP 402, ARG 252 NIL PRO 4, PHE 335 
1a -4.436 ASP 402, GLY 9, THR 6, GLN8, SER 3 ARG 398 PRO 4, PHE 335 
1b -5.372 ASP 402, THR 6 NIL PRO 4, PHE 335 
1c -3.577 ASP 402, THR 6, GLY 9 NIL PRO 4, PHE 335 
1d -5.193 
SER 3, ARG 398, THR11, ARG 10, PRO 
332, ASP 402, GLY 9, THR 6 
NIL 
PRO 4, PHE 335,  




Fig. 3 — FMO of investigated of Schiff base ligand (HL), Cu(II)1a, Ni(II)1b, Co(II)1c and Zn(II)1d 
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χ η σ Pi S ω ΔN max 
HL -5.70 -0.93 4.77 3.31 2.38 0.41 -3.31 0.20 2.30 1.38 
1a -5.16 -4.09 1.07 4.62 0.53 1.86 -4.62 0.93 19.94 8.61 
1b -5.31 -2.85 2.46 4.08 1.23 0.81 -4.08 0.40 6.77 3.31 
1c -5.22 -1.80 3.41 3.51 1.70 0.58 -3.51 0.29 3.62 2.05 








Fig. 5 — Optimized molecular structure of Cu(II)1a, Ni(II)1b, Co(II)1c and Zn(II)1d using B3LYP/LACVP++ basis set 
 
Schroedinger-suite based density functional theory using 
function B3LYP and LACVP++ basis set.
31
 The optimized 
molecular structures of the ligand and metal(II) 
complexes were illustrated in Figs 4 & 5 and the 
selected bond length and bond angle values of the Schiff 
base and its complexes were given in the Table 6 & 7.  
 





Table 6 — Selected optimized geometry parameters of metal (II) complexes (1a-1d) by B3LYP method using LACVP++ basis set 
Bond length (Å ) 
[Cu(HL)] 1a [Ni(HL)] 1b [Co(HL)] 1c [Zn(HL)] 1d 
Cu(37)-N(35) 1.925 Ni(37)-N(35)  1.860 Co(37)-N(35) 1.864 Zn(37)-N(35) 1.898 
Cu(37)-N(17) 1.925 Ni(37)-N(17)  1.860 Co(37)-O(34) 1.863 Zn(37)-N(17) 1.897 
Cu(37)-O(34) 2.054 Ni(37)-O(34)  1.863  Co(37)-O(25) 1.855 Zn(37)-O(34) 2.675 
Cu(37)-O(25) 1.929 Ni(37)-O(25)  1.851 Co(37)-N(17) 1.863 Zn(37)-O(25) 1.946 
Cu(37)-O(16) 2.052 Ni(37)-O(16)  1.863 Co(37)-O(16) 1.863 Zn(37)-O(16) 2.649 
Cu(37)-O(7) 1.929 Ni(37)-O(7)  1.851 Co(37)-O(7) 1.855 Zn(37)-O(7) 1.944 
 
Table 7 — Selected optimized geometry parameters of metal (II) complexes (1a-1d) by B3LYP method using LACVP++ basis set 
Bond angle (deg) 
[Cu(HL)] 1a [Ni(HL)] 1b [Co(HL)] 1c [Zn(HL)] 1d 
N(35)-Cu 
(37)-N(17) 
165.214 N(35)-Ni(37)-O(34) 85.166 N(35)-Co(37)-O(34) 85.099 N(35)-Zn(37)-O(34) 72.152 
N(35)-Cu 
(37)-O(34) 
82.193 N(35)-Ni(37)-O(25) 88.855 N(35)-Co(37)-O(25) 89.504 N(35)-Zn(37)-O(25) 89.508 
N(35)-Cu 
(37)-O(25) 
86.052 N(35)-Ni(37)-N(17) 174.245 N(35)-Co(37)-N(17) 174.311 N(35)-Zn(37)-N(17) 139.924 
N(35)-Cu 
(37)-O(16) 
86.298 N(35)-Ni(37)-O(16) 90.509 N(35)-Co(37)-O(16) 90.651 N(35)-Zn(37)-O(16) 74.113 
N(35)-Cu 
(37)-O(7) 
105.065 N(35)-Ni(37)-O(7) 95.350 N(35)-Co(37)-O(7) 94.744 N(35)-Zn(37)-O(7) 120.783 
N(17)-Cu 
(37)-O(34) 
86.244 O(34)-Ni(37)-O(25) 94.620 O(34)-Co(37)-O(25) 95.749 O(34)-Zn(37)-O(25) 106.117 
N(17)-Cu 
(37)-O(25) 
104.951 O(34)-Ni(37)-N(17) 90.462 O(34)-Co(37)-N(17) 90.561 O(34)-Zn(37)-N(17) 73.518 
N(17)-Cu 
(37)-O(16) 
82.258 O(34)-Ni(37)-O(16) 82.992 O(34)-Co(37)-O(16) 82.964 O(34)-Zn(37)-O(16) 63.905 
N(17)-Cu 
(37)-O(7) 
86.069 O(34)-Ni(37)-O(7) 177.585 O(34)-Co(37)-O(7) 178.726 O(34)-Zn(37)-O(7) 162.331 
O(34)-Cu 
(37)-O(25) 
99.209 O(25)-Ni(37)-N(17) 95.236 O(25)-Co(37)-N(17) 94.597 O(25)-Zn(37)-N(17) 119.683 
O(34)-Cu 
(37)-O(16) 
77.781 O(25)-Ni(37)-O(16) 177.572 O(25)-Co(37)-O(16) 178.685 O(25)-Zn(37)-O(16) 162.662 
O(34)-Cu 
(37)-O(7) 
172.072 O(25)-Ni(37)-O(7) 87.752 O(25)-Co(37)-O(7) 85.513 O(25)-Zn(37)-O(7) 86.935 
O(25)-Cu 
(37)-O(16) 
172.100 N(17)-Ni(37)-O(16) 85.237 N(17)-Co(37)-O(16) 85.159 N(17)-Zn(37)-O(16) 72.627 
O(25)-Cu 
(37)-O(7) 
84.662 N(17)-Ni(37)-O(7) 88.866 N(17)-Co(37)-O(7) 89.513 N(17)-Zn(37)-O(7) 89.768 
O(16)-Cu 
(37)-O(7) 
99.244 O(16)-Ni(37)-O(7) 94.640 O(16)-Co(37)-O(7) 95.775 O(16)-Zn(37)-O(7) 106.153 
 
Conclusions 
In summary of metal(II) complexes (1a-1d) 
derived from Schiff base ligand (HL) and these 
complexes showed three coordination through Schiff 
base ligand. Based on spectroscopic investigations 
and their correlations with the available data of 
known compounds proposed octahedral structures of 
metal complexes have been illustrated. They show 
very good antidiabetic, antioxidant and antimicrobial 
activity of the compounds.All the complexes were 
strongly interact with crystallographic data of  
human pancreatic α-amylase (PDB:1HNY)and the 
best docking score value observed for complex 1b 
was consistent with experimental results obtained 
from an antidiabetic activity. Finally, the frontier 
molecular orbital’s results showed higher activity and 
more stable because of small energy gap for Cu(II)1a 
and lower activity for Co(II)1c complex. Therefore, 
these investigated compounds may be considered as 
promising candidates for further biological purpose. 
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